TriangleFOR PATIENTS · SOURCE READING
Certain factors affect prognosis (chance of recovery) and treatment options.
Source: Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 4, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
The prognosis and treatment options depend on the following:
Source links and citations
The number of blast cells in the bone marrow.
Whether one or more types of blood cells are affected.
Whether the patient has signs or symptoms of anemia, bleeding, or infection.
Whether the patient has a low or high risk of leukemia.
Certain changes in the chromosomes.
Whether the myelodysplastic syndrome occurred after chemotherapy or radiation therapy for cancer.
The patient's age and general health.
Preserved source evidence · Independent clinical review pending · Not medical advice